Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Trends in Pharmacological Sciences | journal | 4.402 Q1 | 244 | 104 | 356 | 5460 | 3669 | 324 | 10.55 | 52.50 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 6.223 Q1 | 70 | 8 | 44 | 1340 | 537 | 44 | 8.71 | 167.50 | |
3 | Advanced Drug Delivery Reviews | journal | 2.778 Q1 | 366 | 107 | 365 | 10459 | 3360 | 303 | 8.61 | 97.75 | |
4 | Natural Product Reports | journal | 2.753 Q1 | 211 | 53 | 128 | 9245 | 950 | 123 | 7.73 | 174.43 | |
5 | Current Opinion in Pharmacology | journal | 2.803 Q1 | 148 | 98 | 308 | 4299 | 2098 | 279 | 7.45 | 43.87 | |
6 | Current Drug Metabolism | journal | 1.835 Q1 | 122 | 65 | 123 | 7593 | 861 | 117 | 6.92 | 116.82 | |
7 | Neuropsychopharmacology | journal | 2.724 Q1 | 249 | 285 | 762 | 16343 | 4804 | 734 | 6.33 | 57.34 | |
8 | Neurotherapeutics | journal | 1.932 Q1 | 136 | 53 | 109 | 4821 | 655 | 98 | 6.01 | 90.96 | |
9 | Nature Reviews Drug Discovery | journal | 7.332 Q1 | 391 | 162 | 916 | 7271 | 5779 | 265 | 5.58 | 44.88 | |
10 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | |
11 | Clinical Pharmacokinetics | journal | 1.534 Q1 | 184 | 82 | 241 | 5255 | 1530 | 238 | 5.41 | 64.09 | |
12 | Journal of Molecular Medicine | journal | 2.697 Q1 | 157 | 116 | 311 | 5708 | 1685 | 293 | 5.31 | 49.21 | |
13 | Particle and Fibre Toxicology | journal | 1.458 Q1 | 119 | 16 | 14 | 852 | 74 | 13 | 5.29 | 53.25 | |
14 | Cellular and Molecular Life Sciences | journal | 2.857 Q1 | 261 | 258 | 782 | 24555 | 4185 | 776 | 5.10 | 95.17 | |
15 | Pharmacogenomics Journal | journal | 1.357 Q1 | 95 | 54 | 158 | 2304 | 673 | 139 | 4.74 | 42.67 | |
16 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | |
17 | Journal of Controlled Release | journal | 1.788 Q1 | 313 | 340 | 996 | 11303 | 4961 | 992 | 4.47 | 33.24 | |
18 | Antiviral Therapy | journal | 1.790 Q1 | 93 | 126 | 326 | 4438 | 1413 | 312 | 4.46 | 35.22 | |
19 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 1.205 Q1 | 50 | 10 | 17 | 1137 | 75 | 17 | 4.41 | 113.70 | |
20 | Neuropharmacology | journal | 1.921 Q1 | 191 | 229 | 730 | 10800 | 3166 | 727 | 4.37 | 47.16 | |
21 | Journal of Nanobiotechnology | journal | 1.124 Q1 | 109 | 14 | 27 | 465 | 106 | 27 | 4.33 | 33.21 | |
22 | Controlled Clinical Trials | journal | 1.648 Q1 | 76 | 0 | 117 | 0 | 406 | 106 | 4.30 | 0.00 | |
23 | International Journal of Neuropsychopharmacology | journal | 1.777 Q1 | 125 | 95 | 201 | 3483 | 855 | 169 | 4.22 | 36.66 | |
24 | Psychopharmacology | journal | 1.892 Q1 | 214 | 366 | 1156 | 19456 | 5043 | 1107 | 4.18 | 53.16 | |
25 | Journal of Antimicrobial Chemotherapy | journal | 1.771 Q1 | 221 | 485 | 1381 | 11635 | 5642 | 1169 | 4.07 | 23.99 | |
26 | European Neuropsychopharmacology | journal | 1.382 Q1 | 130 | 91 | 258 | 4338 | 995 | 256 | 4.03 | 47.67 | |
27 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.446 Q1 | 99 | 24 | 48 | 3594 | 210 | 45 | 4.00 | 149.75 | |
28 | Drug and Alcohol Dependence | journal | 1.854 Q1 | 187 | 210 | 463 | 8779 | 1946 | 452 | 3.93 | 41.80 | |
29 | European Journal of Pharmaceutics and Biopharmaceutics | journal | 1.313 Q1 | 185 | 131 | 384 | 3603 | 1353 | 377 | 3.84 | 27.50 | |
30 | Human Genomics | journal | 2.394 Q1 | 68 | 33 | 65 | 1350 | 246 | 61 | 3.83 | 40.91 | |
31 | Toxicological Sciences | journal | 1.327 Q1 | 207 | 333 | 894 | 14700 | 3449 | 860 | 3.83 | 44.14 | |
32 | Critical Reviews in Toxicology | journal | 1.537 Q1 | 129 | 29 | 69 | 4381 | 317 | 63 | 3.80 | 151.07 | |
33 | Apoptosis : an international journal on programmed cell death | journal | 1.761 Q1 | 128 | 192 | 283 | 9438 | 1189 | 281 | 3.73 | 49.16 | |
34 | BioDrugs | journal | 0.786 Q2 | 79 | 42 | 125 | 2488 | 383 | 123 | 3.70 | 59.24 | |
35 | Current Drug Targets: Inflammation and Allergy | journal | 1.209 Q1 | 53 | 0 | 172 | 0 | 620 | 159 | 3.62 | 0.00 | |
36 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | |
37 | Antiviral Research | journal | 1.139 Q1 | 151 | 118 | 262 | 5565 | 980 | 260 | 3.40 | 47.16 | |
38 | Pharmacogenomics | journal | 0.939 Q2 | 100 | 115 | 282 | 4762 | 853 | 244 | 3.40 | 41.41 | |
39 | Investigational New Drugs | journal | 1.068 Q1 | 97 | 64 | 165 | 2161 | 577 | 162 | 3.27 | 33.77 | |
40 | Expert Opinion on Biological Therapy | journal | 0.910 Q2 | 102 | 118 | 426 | 10116 | 1358 | 420 | 3.26 | 85.73 | |
41 | Drug Discovery Today | journal | 1.251 Q1 | 215 | 161 | 1060 | 7603 | 3278 | 847 | 3.22 | 47.22 | |
42 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 0.849 Q1 | 69 | 0 | 261 | 0 | 781 | 254 | 3.16 | 0.00 | |
43 | Toxicology Letters | journal | 1.018 Q1 | 163 | 241 | 752 | 8608 | 2457 | 733 | 3.16 | 35.72 | |
44 | Toxicology | journal | 1.034 Q1 | 176 | 311 | 823 | 12263 | 2840 | 810 | 3.14 | 39.43 | |
45 | Environmental Pollution | journal | 1.679 Q1 | 301 | 433 | 889 | 16737 | 2998 | 881 | 3.09 | 38.65 | |
46 | Journal of Psychopharmacology | journal | 1.183 Q1 | 135 | 144 | 275 | 6477 | 851 | 238 | 3.09 | 44.98 | |
47 | Current Pharmaceutical Biotechnology | journal | 1.000 Q1 | 97 | 60 | 145 | 4656 | 459 | 129 | 3.08 | 77.60 | |
48 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | |
49 | Expert Opinion on Emerging Drugs | journal | 0.708 Q2 | 54 | 46 | 116 | 5338 | 331 | 116 | 3.06 | 116.04 | |
50 | NeuroToxicology | journal | 0.978 Q1 | 133 | 136 | 283 | 6124 | 852 | 278 | 3.06 | 45.03 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®